Bluejay Therapeutics

Closed

Bluejay Therapeutics was founded in 2020, is headquartered in San Mateo, United States, lists 11–50 employees, and has $223.0M in recorded funding across 2 rounds.

Headquarters
San Mateo
Employees
11–50
Founded
2020
Total Funding
$223.0M
Last Round
$182.0M Series CMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Bluejay Therapeutics is a clinical-stage biopharmaceutical developer focused on potentially life-changing treatments for viral hepatitis and liver diseases. The company is investigating BJT-778 for chronic hepatitis B and chronic hepatitis D. It is also advancing programs targeting chronic hepatitis B, including the TLR9 agonist cavrotolimod and liver-targeted hepatitis B virus transcript inhibitor BJT-628, toward a combination regimen intended to achieve a functional cure.

Summary

Bluejay Therapeutics is a Biotech company based in San Mateo, United States, founded in 2020. It lists 11–50 employees. It has raised $223.0M in total across 2 rounds, most recently a $182.0M Series C round in May 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMay 2024
$182.0M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bluejay Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/bluejay-therapeutics"><img src="https://indexed.vc/api/badge/company/bluejay-therapeutics" alt="Bluejay Therapeutics on Indexed.vc" width="260" height="76" /></a>